Westwood Holdings Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59M Buy
3,901
+319
+9% +$323K 0.03% 302
2025
Q4
$3.85M Sell
3,582
-39
-1% -$37.3K 0.03% 293
2025
Q3
$2.76M Sell
3,621
-979
-21% -$729K 0.02% 319
2025
Q2
$3.59M Sell
4,600
-479
-9% -$372K 0.03% 289
2025
Q1
$4.19M Sell
5,079
-197
-4% -$164K 0.03% 272
2024
Q4
$4.07M Buy
5,276
+1,410
+36% +$1.17M 0.03% 280
2024
Q3
$3.43M Sell
3,866
-46
-1% -$41.4K 0.01% 313
2024
Q2
$3.54M Buy
3,912
+73
+2% +$58.4K 0.02% 298
2024
Q1
$2.99M Buy
3,839
+196
+5% +$139K 0.02% 279
2023
Q4
$2.12M Hold
3,643
0.02% 299
2023
Q3
$1.96M Sell
3,643
-266
-7% -$137K 0.02% 297
2023
Q2
$1.83M Sell
3,909
-131
-3% -$54.9K 0.02% 306
2023
Q1
$1.39M Buy
4,040
+148
+4% +$49.9K 0.01% 330
2022
Q4
$1.42M Hold
3,892
0.01% 324
2022
Q3
$1.26M Buy
3,892
+3
+0.1% +$951 0.01% 300
2022
Q2
$1.26M Sell
3,889
-17
-0.4% -$5.1K 0.01% 324
2022
Q1
$1.12M Sell
3,906
-123
-3% -$31.7K 0.01% 352
2021
Q4
$1.11M Buy
4,029
+119
+3% +$30.2K 0.01% 344
2021
Q3
$903K Buy
3,910
+6
+0.2% +$1.48K 0.01% 351
2021
Q2
$896K Buy
3,904
+28
+0.7% +$5.62K 0.01% 350
2021
Q1
$724K Buy
3,876
+379
+11% +$74.1K 0.01% 359
2020
Q4
$591K Sell
3,497
-157
-4% -$23.4K 0.01% 362
2020
Q3
$541K Sell
3,654
-18
-0.5% -$2.79K 0.01% 352
2020
Q2
$603K Buy
3,672
+18
+0.5% +$2.76K 0.01% 351
2020
Q1
$507K Hold
3,654
0.01% 344
2019
Q4
$481K Sell
3,654
-8
-0.2% -$927 0.01% 388
2019
Q3
$410K Buy
3,662
+45
+1% +$5.01K ﹤0.01% 381
2019
Q2
$401K Hold
3,617
﹤0.01% 409
2019
Q1
$469K Hold
3,617
﹤0.01% 354
2018
Q4
$419K Hold
3,617
﹤0.01% 347
2018
Q3
$388K Buy
3,617
+157
+5% +$15.7K ﹤0.01% 358
2018
Q2
$295K Hold
3,460
﹤0.01% 387
2018
Q1
$268K Sell
3,460
-8
-0.2% -$644 ﹤0.01% 389
2017
Q4
$293K Hold
3,468
﹤0.01% 379
2017
Q3
$297K Buy
3,468
+858
+33% +$70.4K ﹤0.01% 376
2017
Q2
$215K Buy
+2,610
New +$213K ﹤0.01% 390

Other funds holding LLY

Westwood Holdings Group's LLY Position: Q1 2026 in Review

Westwood Holdings Group increased its Eli Lilly (LLY) stake by 8.9% in Q1 2026, buying an estimated $323K and bringing the position to 3,901 shares worth $3.59M. The position accounts for 0.03% of the portfolio, ranked #302.

Westwood Holdings Group first reported a position in LLY in Q2 2017 and has held it in 36 quarters since. The position peaked at $4.19M in Q1 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Westwood Holdings Group held 3,901 shares of Eli Lilly worth $3.59M as of Q1 2026.
  • Westwood Holdings Group bought 319 Eli Lilly shares in Q1 2026, an estimated $323K.
  • Eli Lilly made up 0.03% of Westwood Holdings Group's portfolio in Q1 2026, its #302 holding.
  • Westwood Holdings Group first reported a position in Eli Lilly in Q2 2017 and has held it in 36 quarters since.
  • Westwood Holdings Group's Eli Lilly position peaked at $4.19M in Q1 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Westwood Holdings Group's 13F filing for Q1 2026, filed 15 May 2026.